Analysis of Radiolytically Generated Gases in Mini-AMORE Experiment

Technical Report · Tue May 01 04:00:00 EDT 2018

DOI:https://doi.org/10.2172/1463259· OSTI ID:1463259

Kalensky, Michael ^[1]; Youker, Amanda J. ^[1]; Chemerisov, Sergey D. ^[1]; Brossard, Thomas ^[1]

---

1. Argonne National Lab. (ANL), Argonne, IL (United States)

Argonne National Laboratory (Argonne) is assisting one of the potential domestic Mo-99 producers, SHINE Medical Technologies, as part of the National Nuclear Security Administration’s (NNSA) Office of Material, Management, and Minimization (M³) program in the development of a domestic Mo-99 production pathway that does not use highly enriched uranium (HEU). The process proposed by SHINE would produce Mo-99 by neutron-induced fission of a low enriched uranium (LEU) solution as uranyl sulfate in a subcritical assembly. As part of the development effort, Argonne is undertaking the AMORE (Argonne Molybdenum Research Experiment) project, which is essentially a pilot facility for all phases of Mo-99 production, recovery, and purification. Mini-AMORE is a part of the AMORE experiment where 2 mL samples of uranyl sulfate solution are inserted in the dry well of the AMORE target solution vessel.

• Research Organization: Argonne National Lab. (ANL), Argonne, IL (United States)
• Sponsoring Organization: USDOE National Nuclear Security Administration (NNSA), Office of Defense Nuclear Nonproliferation (NA-20). Office of Material Management and Minimization (M3)
• DOE Contract Number: AC02-06CH11357
• OSTI ID: 1463259
• Report Number(s): ANL/CFC--18/3; 145486
• Country of Publication: United States
• Language: English

Related Subjects

07 ISOTOPE AND RADIATION SOURCES
Mo-99
radiolysis
uranyl peroxide